NUVISAN The Science CRO
Danny Schnerwitzki has a strong background in research and development, with a focus on aging and metabolism. Danny has served as a Laboratory Head and Associate Scientist in Cross Indication Research at Nuvisan, where their responsibilities included project management, animal experimentation, and customer care. Prior to their work at Nuvisan, they were a Postdoctoral Scientist at Charité, conducting research in protein biochemistry and supervising students. Danny also has experience as a Postdoctoral Scientist and Graduate Research Associate at the Fritz Lipmann Institute, specializing in neuroscience and developmental biology. Furthermore, they have worked as a Research Intern at the University of Hull and as an Undergraduate Research Assistant at the Max Planck Institute for Chemical Ecology, gaining further expertise in molecular parasitology and defense strategies in conifers, respectively.
Danny Schnerwitzki completed their education in a chronological manner. Danny pursued a Diploma in Biochemistry and Molecular Biology from Friedrich Schiller University Jena, which they obtained between 2007 and 2012. Following this, they pursued a Doctor of Philosophy - PhD in Molecular Genetics at the same university, completing it between 2012 and 2017. In addition to their degrees, Danny Schnerwitzki obtained a certification as a Project Manager for Laboratory Animal Science according to guidelines of the Federation of European Laboratory Animal Science (FELASA), category C in November 2016. This certification was obtained from the institution Berliner Kompaktkurse.
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.